Search for: "CELGENE"
Results 21 - 40
of 181
Sorted by Relevance
|
Sort by Date
8 Nov 2021, 9:15 am
Court of Appeals for the Federal Circuit (CAFC) issued a precedential decision in Celgene Corp. v. [read post]
21 Nov 2019, 2:15 pm
Both Celgene’s en banc petition and the government’s response address the merits of Celgene’s constitutional claim—but as we hinted at in an earlier article analyzing the Celgene decision, there is a serious question whether the Federal Circuit should have even reached the merits of the Takings Clause issue in its panel opinion. [read post]
2 Jan 2009, 2:39 pm
The Dow Jones (12/31, Dooren) reported, "The Food and Drug Administration said Wednesday Celgene Corp. [read post]
2 Jan 2009, 2:36 pm
The Dow Jones (12/31, Dooren) reported, "The Food and Drug Administration said Wednesday Celgene Corp. [read post]
6 Apr 2020, 10:03 am
Law professors recently filed an amicus brief in support of the Celgene's petition for writ of certiorari to take up Celgene Corp v. [read post]
14 Apr 2020, 1:20 pm
Just as it did in other cases raising Patent Trial and Appeal Board (PTAB)-related Takings Clause issues, the appellate court in Golden relied on its July 2019 decision in Celgene Corp. v. [read post]
21 Nov 2019, 2:15 pm
Nearly four months ago, the Federal Circuit for the first time addressed the applicability of the Takings Clause of the Fifth Amendment to IPRs, holding in Celgene Corp v. [read post]
8 Nov 2021, 9:15 am
Court of Appeals for the Federal Circuit (CAFC) issued a precedential decision in Celgene Corp. v. [read post]
11 Aug 2019, 9:15 am
The case of Celgene Corp. v. [read post]
21 Jun 2010, 7:29 am
There are some obligations as well: He can’t compete with Celgene through 2013, for example. [read post]
21 Nov 2017, 6:15 am
Celgene faces a new gang of generics moving in on its blockbuster Revlimid®. [read post]
5 Nov 2021, 8:29 am
Celgene appeals. [read post]
12 Jan 2019, 10:12 am
On January 11, 2019, Congressman Peter Welch and Francis Rooney, members of Congress, wrote a letter to the Federal Trade Commission (“FTC”), urging the Commission to investigate Bristol-Myers Squibb’s (“BMS”) acquisition of Celgene. [read post]
2 Aug 2019, 9:43 am
This week in Other Barks & Bites: The Federal Circuit issues several precedential decisions, including one reviving the patent claims in VirnetX and another determining that America Invents Act (AIA) validity trials don’t violate the Fifth Amendment’s Takings Clause in Celgene. [read post]
10 May 2010, 9:34 pm
Celgene and Novartis brought suit claiming infringement of Celgene's U.S. [read post]
3 Jun 2010, 9:36 pm
By James DeGiulio -- Celgene, Barr Resolve Patent Dispute over Generic Thalomid Celgene Corp. and Barr Laboratories Inc. have resolved their patent dispute over the multiple myeloma cancer drug Thalomid, with Celgene agreeing to drop its patent infringement claims and Barr dropping its invalidity and antitrust claims. [read post]
11 Aug 2019, 9:15 am
The case of Celgene Corp. v. [read post]
17 Jun 2015, 10:44 am
Celgene Corp., 985 F. [read post]
4 Aug 2008, 4:39 am
Celgene and Novartis v. [read post]
14 Apr 2020, 1:20 pm
Just as it did in other cases raising Patent Trial and Appeal Board (PTAB)-related Takings Clause issues, the appellate court in Golden relied on its July 2019 decision in Celgene Corp. v. [read post]
